selected publications
- Author Correction: BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity. 2026 GET IT
- PIP2 Binding at Allosteric Site Blocks Activation in Human Rod CNG Channels. 2025 GET IT
- Stronger binding affinities of gp120/CD4 in Catarrhini provide insights into HIV/host interactions. Infectious Disease Modelling. 2024 Academic Article GET IT
-
Crystal structure of [1,2,4]triazolo[4,3-b]pyridazine derivatives as BRD4 bromodomain inhibitors and structure-activity relationship study.
Scientific reports.
2023
Academic Article
GET IT
Times cited: 3 -
BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity.
Experimental & molecular medicine.
2022
Academic Article
GET IT
Times cited: 22 -
Phospholipid transfer function of PTPIP51 at mitochondria-associated ER membranes.
EMBO reports.
2021
Academic Article
GET IT
Times cited: 97 -
Synthesis and Structure-Activity Relationships of Aristoyagonine Derivatives as Brd4 Bromodomain Inhibitors with X-ray Co-Crystal Research.
Molecules (Basel, Switzerland).
2021
Academic Article
GET IT
Times cited: 11 -
Crystal Structure of the Kinase Domain of MerTK in Complex with AZD7762 Provides Clues for Structure-Based Drug Development.
International journal of molecular sciences.
2020
Academic Article
GET IT
Times cited: 6